Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, October 24 2014 3:58am ET - U.S. Markets open in 5 hours and 32 minutes.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Diagnostic Substances News
Latest News
Thursday, Oct 23, 2014
·Trinity Biotech Announces Quarter 3 Financial Results and Temporary Suspension of Meritas Troponin Trials
GlobeNewswire - Thu 9:01 am ET
·Chembio to Host Conference Call to Discuss Third Quarter 2014 Financial Results
GlobeNewswire - Thu 8:50 am ET
Wednesday, Oct 22, 2014
·Atossa Genetics Receives CE Mark for the ForeCYTE Breast Aspirator Device
Marketwire - Wed 8:00 am ET
Tuesday, Oct 21, 2014
·Quidel beats Street 3Q forecasts
AP - Tue Oct 21
·Quidel Reports Third Quarter 2014 Financial Results
Marketwire - Tue Oct 21
Monday, Oct 20, 2014
·Should You Buy AMAG Pharmaceuticals (AMAG) Ahead of Earnings? - Mon Oct 20
Thursday, Oct 16, 2014
·Trinity Biotech (TRIB) Downgraded From Buy to Hold
at - Thu Oct 16
Wednesday, Oct 15, 2014
·Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Human Parainfluenza Viruses (HPIV), Types 1, 2 and 3
Marketwire - Wed Oct 15
Tuesday, Oct 14, 2014
·Venaxis Announces APPY1 Test Clinical Trial Results to be Presented at ACEP14
PR Newswire - Tue Oct 14
·IDEXX Laboratories to Release 2014 Third Quarter Financial Results
PR Newswire - Tue Oct 14
Monday, Oct 13, 2014
·Quidel Receives FDA Clearance for Its Lyra(R) Molecular PCR Assay for the Detection of Adenovirus
Marketwire - Mon Oct 13
Wednesday, Oct 8, 2014
·Palatin Technologies To Present At The 13th Annual BIO Investor Forum
PR Newswire - Wed Oct 8
Monday, Oct 6, 2014
·Quidel to Hold Third Quarter 2014 Financial Results Conference Call on October 21, 2014
Marketwire - Mon Oct 6
·Atossa Genetics to Present at the 13th Annual BIO Investor Forum October 8, 2014
Marketwire - Mon Oct 6
·Trinity Biotech plc to Announce Third Quarter Fiscal 2014 Financial Results
GlobeNewswire - Mon Oct 6
Thursday, Oct 2, 2014
·Can the Rally in AMAG Pharmaceuticals (AMAG) Shares Continue? - Thu Oct 2
Wednesday, Oct 1, 2014
·Neogen acquires BioLumix
PR Newswire - Wed Oct 1
·IDEXX Announces Several Milestones in its US All-Direct CAG Distribution Strategy
PR Newswire - Wed Oct 1
·SecureAlert, Inc. Becomes Track Group in Corporate Rebranding
PR Newswire - Wed Oct 1
Monday, Sep 29, 2014
·Amag Pharma enters women health business with $675 mln deal
Reuters - Mon Sep 29
More Latest News...
Sponsor Results
Medical Equipment Store
Deliver and Install Same Day We have Everything
IVD Regulatory Changes
Free Webinar- Prepare for upcoming changes in the EU and US.
Apply for Disability
Are you eligible for up to $2642/mo in Social Security Disability?
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Diagnostic Substances Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?